Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Breast cancer biomarkers and molecular medicine.

Expert review of molecular diagnostics - 1 Sept 2003

Ross Jeffrey S, Linette Gerald P, Stec James, Clark Edwin, Ayers Mark, Leschly Nick, Symmans W Fraser, Hortobagyi Gabriel N, Pusztai Lajos

Abstract excerpt

The first part of this two-part review of established and emerging breast cancer biomarkers and molecular diagnostics considers breast cancer predisposition, screening tests for diagnosis, diagnosis using small specimens and metastatic lesions, micrometastatic disease and breast cancer prognosis assessment. Prognostic factors covered in this review include: cytogenetic markers, DNA ploidy and S phase...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle
Share to Antibodies, Monoclonal, Humanized

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, erbB-2

Share to Growth Substances

Share to Mass Screening

Share to Molecular Diagnostic Techniques

Share to Receptors, Cell Surface

Share to Trastuzumab

Source

Identifiers

PMID: 14510178
DOI: 10.1586/14737159.3.5.573

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Breast cancer biomarkers and molecular medicine.PMID 14510178Read ↗

Current and emerging breast cancer biomarkersSemantic proximity Read ↗

Breast Cancer: Epidemiology, Molecular Classification, Diagnostics and Evolving Treatment Paradigms.Semantic proximity Read ↗

Prognostic and predictive biomarkers with therapeutic targets in breast cancer: A 2022 update on current developments, evidence, and recommendationsSemantic proximity Read ↗

Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific TreatmentsSemantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.Semantic proximity Read ↗

Molecular screening for breast cancer prevention, early detection, and treatment planning: combining biomarkers from DNA, RNA, and protein.Semantic proximity Read ↗

Breast Molecular Profiling and Radiotherapy Considerations.Semantic proximity Read ↗

Advances in prognostic and predictive biomarkers for breast cancer: Integrating multigene assays, hormone receptors, and emerging circulating biomarkersSemantic proximity Read ↗

Current advances in the diagnosis and personalized treatment of breast cancer: lessons from tumor biology.Semantic proximity Read ↗

Biomarker assessment and molecular testing for prognostication in breast cancerSemantic proximity Read ↗

Cancer Hallmarks, Biomarkers and Breast Cancer Molecular SubtypesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.